Acute Disseminated Encephalomyelitis in a 2-Year-Old Patient Following COVID-19

Abstract

This report presents the case of acute disseminated encephalomyelitis in a 2-year-old patient following a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test. She presented with ataxic gait, truncal ataxia, and reduced coordination following 10 days of intermittent fever and lethargy. She did not have any respiratory symptoms. Magnetic resonance imaging of the brain and spine showed widespread T2 high signal within the gray and white matters and within the spinal cord. She was treated with intravenous methylprednisolone followed by tapering oral prednisolone; this led to resolution of her neurological symptoms. This case highlights that neurological complications can occur secondary to SARS-CoV-2 infection.

Keywords

coronavirus - acute disseminated encephalomyelitis - neurology - pediatrics

Publikationsverlauf

Eingereicht: 13. Juli 2021

Angenommen: 21. September 2021

Artikel online veröffentlicht:
25. November 2021

• References

• 1 Swann OV, Holden KA, Turtle L. et al; ISARIC4C Investigators. Clinical characteristics of children and young people admitted to hospital with COVID-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 2020; 370: m3249
• 2 Panda PK, Sharawat I, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological complications of SARS-CoV-2 infection in children: a systematic review and meta-analysis. J Trop Pediatr 2021; 67 (03) fmaa070
• 3 Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J 2003; 79 (927) 11-17
• 4 Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 2008; 28 (01) 84-94
• 5 COVID-19 Infection Survey: methods and further information. The Office for National Statistics Section 5: Test sensitivity and specificity. Last revised 24th August 2021. Accessed September 3, 2021 at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/methodologies/covid19infectionsurveypilotmethodsandfurtherinformation
• 6 Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000; 123 (Pt 12): 2407-2422
• 7 Anlar B, Basaran C, Kose G. et al. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics 2003; 34 (04) 194-199
• 8 Ketelslegers IA, Van Pelt DE, Bryde S. et al. Anti-MOG antibodies plead against MS diagnosis in an acquired demyelinating syndromes cohort. Mult Scler 2015; 21 (12) 1513-1520
• 9 Mehra B, Aggarwal V, Kumar P. et al. COVID-19-associated severe multisystem inflammatory syndrome in children with encephalopathy and neuropathy in an adolescent girl with the successful outcome: an unusual presentation. Indian J Crit Care Med 2020; 24 (12) 1276-1278
• 10 Tiwari L, Shekhar S, Bansal A, Kumar S. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report. Lancet Child Adolesc Health 2021; 5 (01) 88-90
• 11 García-Howard M, Herranz-Aguirre M, Moreno-Galarraga L. et al. Case report: benign infantile seizures temporally associated with COVID-19. Front Pediatr 2020; 8: 507
• 12 Lindan C, Mankad K, Ram D. et al; ASPNR PECOBIG Collaborator Group. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health 2021; 5 (03) 167-177
• 13 Najjar S, Najjar A, Chong DJ. et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation 2020; 17 (01) 231
• 14 de Miranda Henriques-Souza AM, de Melo ACMG, de Aguiar Coelho Silva Madeiro B, Freitas LF, Sampaio Rocha-Filho PA, Gonçalves FG. Acute disseminated encephalomyelitis in a COVID-19 pediatric patient. Neuroradiology 2021; 63 (01) 141-145
• 15 Jiang L, Tang K, Levin M. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20 (11) e276-e288
• 16 Krupp LB, Tardieu M, Amato MP. et al; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19 (10) 1261-1267
• 17 Murthy SN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics 2002; 110 (2 Pt 1): e21
• 18 Held F, Kalluri SR, Berthele A, Klein AK, Reindl M, Hemmer B. Frequency of myelin oligodendrocyte glycoprotein antibodies in a large cohort of neurological patients. Mult Scler J Exp Transl Clin 2021;7(02):20552173211022767
• 19 Dos Passos GR, Oliveira LM, da Costa BK. et al. MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol 2018; 9: 217
• 20 Hennes EM, Baumann M, Schanda K. et al; BIOMARKER Study Group. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 2017; 89 (09) 900-908